About this trial
The goal of this study is to adapt an existing evidence based intervention for use in pregnant and lactating people (PLP) who use alcohol. Through the pilot RCT, we aim to understand if tailored intervention, Mentor Mothers+, is effective in reducing alcohol use (primary outcome) and improving antiretroviral (PrEP or ART) adherence (secondary outcomes) among pregnant and breastfeeding women living with and without HIV in a community heavily burdened by this syndemic.
The investigators will conduct an pilot randomized control trial in 100 pregnant women, recruited during antenatal care (ANC) visits within the Saldanha Bay Municipality clinic in Cape Town, South Africa. The RCT will involve the delivery of brief, individual motivational interviewing sessions provided by trained mentor mothers from the community who are on either PrEP (living without HIV) or ART (living with HIV) and who stopped or reduced alcohol use during pregnancy. The enrolled participants will be followed for a 6-month period spanning both pregnancy and postpartum stages.
Eligibility criteria
Qualifiers
• ≥ 16 years;
Pregnancy confirmed;
reported alcohol use during pregnancy (in last 2 months);
lives within 20 kilometers of the study facility;
Disqualifiers
Individuals not meeting the above criteria will be excluded.
Trial design
Treatments tested in this trial
- MM+
- Enhanced HIV attention control (eSOC)
Treatment groups
Sponsors and collaborators
University of California, Los Angeles
Lead sponsor
University of Cape Town
Collaborator
San Diego State University
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator